UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000047620
Receipt No. R000054303
Scientific Title Impact of Perfluoron Carbon on Postoperative Outcomes by Retinal Detachment Type
Date of disclosure of the study information 2022/04/28
Last modified on 2022/04/28 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Impact of Perfluoron Carbon on Postoperative Outcomes by Retinal Detachment Type
Acronym Impact of PFCL on Postoperative Outcomes by RD Type
Scientific Title Impact of Perfluoron Carbon on Postoperative Outcomes by Retinal Detachment Type
Scientific Title:Acronym Impact of PFCL on Postoperative Outcomes by RD Type
Region
Japan

Condition
Condition retinal detachment
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine whether the use of PFCL for rhegmatogenous retinal detachment (RRD) other than refractory retinal detachment affects the frequency of retinal re-detachment after initial surgery.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Frequency of reablation incidence at 6 months postoperatively for initial surgery for RRD.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria RRD patients diagnosed between February 1, 2016 and March 31, 2017 who underwent vitrectomy
Key exclusion criteria Cases with missing key information
Cases with unknown PFCL use
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Masahiko
Middle name
Last name Sugimoto
Organization Mie University
Division name Department of Ophthalmology, Graduate School of Medicine
Zip code 514-8507
Address Edobashi
TEL 0592315027
Email sugmochi@clin.medic.mie-u.ac.jp

Public contact
Name of contact person
1st name Masahiko
Middle name
Last name Sugimoto
Organization Mie University
Division name Department of Ophthalmology, Graduate School of Medicine
Zip code 514-8507
Address 2-174, Edobashi, Tsu, Mie, Japan
TEL 0592315027
Homepage URL
Email sugmochi@clin.medic.mie-u.ac.jp

Sponsor
Institute Mie University
Institute
Department

Funding Source
Organization Mie University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Mie University
Address 2-174, Edobashi, Tsu, Mie, Japan
Tel 0592315027
Email sugmochi@clin.medic.mie-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 04 Month 28 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2022 Year 04 Month 15 Day
Date of IRB
2022 Year 04 Month 15 Day
Anticipated trial start date
2022 Year 04 Month 15 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The use of perfluorocarbons (PFCLs) for refractory retinal detachments such as proliferative vitreoretinopathy (PVR) and giant retinal detachments has been approved and their usefulness is known. In this study, we will examine whether the use of PFCL for rhegmatogenous retinal detachment (RRD) other than refractory retinal detachment affects the frequency of retinal re-detachment after initial surgery using the Vitreoretinal Surgery Treatment Information Database established by the Japanese Society for Vitreoretinal Research.

Management information
Registered date
2022 Year 04 Month 28 Day
Last modified on
2022 Year 04 Month 28 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054303